V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

iRhythm Holdings Executive Compensation (FY25)

IRTC · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): May 28, 2026
236 figures on this page: 228 cited to the filing that reported them, 8 calculated from figures it prints. See the citations
Total compensation for Quentin Blackford, President, Chief Executive Officer and Director, came to $11,003,163 in fiscal 2025, and Blackford's total moved 17.8% higher from the $9,343,903 reported for fiscal 2024. The company reported a chief executive pay ratio of 96.6:1 for fiscal 2025, against median employee compensation of $113,889. For fiscal 2025, shareholders backed the say-on-pay proposal with 95.7% of votes cast including abstentions in favor at the meeting held May 27, 2026. Companies named in the disclosed peer group include Alphatec, AtriCure, Inc., Fulgent Genetics, Inc., Globus Medical, Inc. and Inspire Medical Systems, Inc., among others.
Chief executive, fiscal 2025
◇
Quentin Blackford
Latest say-on-pay support
=
May 27, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Quentin Blackford: $9,343,903 → $11,003,163 (17.8% higher)
Say-on-pay support: 96.0% → 95.7% (0.3 points lower)
CEO pay ratio: 86.2:1 → 96.6:1 (12.1% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is iRhythm Holdings' chief executive and what were they paid?
Total compensation for Quentin Blackford, President, Chief Executive Officer and Director, came to $11,003,163 in fiscal 2025. Blackford's total moved 17.8% higher from the $9,343,903 reported for fiscal 2024.
What was iRhythm Holdings' say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 95.7% of votes cast including abstentions in favor at the meeting held May 27, 2026.
Which companies are in iRhythm Holdings' peer group?
Companies named in the disclosed peer group include Alphatec, AtriCure, Inc., Fulgent Genetics, Inc., Globus Medical, Inc. and Inspire Medical Systems, Inc., among others.
What is iRhythm Holdings' chief executive pay ratio?
The company reported a chief executive pay ratio of 96.6:1 for fiscal 2025, against median employee compensation of $113,889.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Quentin Blackford
President and Chief Executive Officer
◇—◇—◇—◇◇
Chad Patterson
Chief Commercial Officer
◇—◇—◇—◇◇
Patrick Murphy
Chief Business Officer and Chief Legal Officer
◇—◇—◇—◇◇
Minang Turakhia
Chief Medical and Scientific Officer, and EVP, Advanced Technologies
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Quentin Blackford
President, Chief Executive Officer and Director
◇—◇—◇—◇◇
Chad Patterson
Chief Commercial Officer
◇—◇—◇—◇◇
Minang Turakhia
Chief Medical Officer, Chief Scientific Officer, and EVP, Product Innovation
◇—◇—◇—◇◇
Patrick Murphy
Chief Business Officer and Chief Legal Officer
◇—◇—◇—◇◇
Brice Bobzien
Former Chief Financial Officer
Departed during or after this year
◇—◇—◇—◇◇
Daniel Wilson
Chief Financial Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Quentin Blackford
President, Chief Executive Officer and Director
◇—◇—◇—◇◇
Chad Patterson
Chief Commercial Officer
◇—◇—◇—◇◇
Minang Turakhia
Chief Medical Officer, Chief Scientific Officer, and EVP, Advanced Technologies
◇—◇—◇—◇◇
Patrick Murphy
Chief Business Officer and Chief Legal Officer
◇—◇—◇—◇◇
Daniel Wilson
Chief Financial Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Chad PattersonPSU—◇◇—◇—◇
Chad PattersonRSU———◇——◇
Daniel WilsonRSU———◇——◇
Daniel WilsonPSU—◇◇—◇—◇
Patrick MurphyPSU—◇◇—◇—◇
Patrick MurphyRSU———◇——◇
Quentin BlackfordPSU—◇◇—◇—◇
Quentin BlackfordRSU———◇——◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Patrick MurphyRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Chad PattersonRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Quentin BlackfordRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Daniel WilsonRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Minang TurakhiaRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin O'Boyle
◇◇————◇
Karen McGinnis
◇◇————◇
Abhijit Talwalkar
Board chair
◇◇————◇
Brian Yoor
◇◇————◇
Bruce Bodaken
◇◇————◇
Karen Ling
◇◇————◇
C. Noel Bairey Merz
◇◇————◇
Mark Rubash
◇◇————◇
Ralph Snyderman
◇◇————◇
Mojdeh Poul
◇—————◇
Jason Patten and Quentin Blackford served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alphatec ATEC
  • AtriCure, Inc. ATRC
  • Fulgent Genetics, Inc. FLGT
  • Globus Medical, Inc. GMED
  • Inspire Medical Systems, Inc. INSP
  • Insulet Corporation PODD
  • Integra LifeSciences IART
  • Lantheus Holdings, Inc. LNTH
  • LivaNova PLC LIVN
  • Masimo Corporation MASI
  • Natera Inc. NTRA
  • Penumbra, Inc. PEN
  • ResMed, Inc RMD
  • Tactile Systems Technology TCMD
  • Tandem Diabetes Care, Inc. TNDM

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 27, 2026=◇◇◇
2024May 28, 2025=◇◇◇
2023May 29, 2024=◇◇◇
2022May 24, 2023=◇◇◇
2021May 26, 2022=◇◇◇
2020June 18, 2021=◇◇◇
2019June 19, 2020=◇◇◇
2018May 22, 2019=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when iRhythm Holdings files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact iRhythm Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where iRhythm Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether iRhythm Holdings' disclosed peer group is defensible, who names iRhythm Holdings back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
236 figures on this page: 228 cited to the filing that reported them, 8 calculated from figures it prints.
228 cited to the filing
8 calculated from the filing

Documents cited

  1. 0001388658-26-000049
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001388658-26-000030
    2025 Grants of Plan-Based Awards Table · 2025 Summary Compensation Table · CEO Pay Ratio · Director Compensation · and 3 more sections
  3. 0001388658-25-000141
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001388658-25-000078
    2024 Summary Compensation Table
  5. 0001388658-24-000106
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001388658-24-000079
    2023 Summary Compensation Table
  7. 0001388658-23-000067
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001388658-22-000084
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001388658-21-000096
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001388658-20-000126
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001564590-19-020326
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “iRhythm Holdings executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/IRTC (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about iRhythm Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers iRhythm Holdings discloses

The companies named in IRTC's own disclosed peer group.

AtriCure, Inc.Globus Medical, Inc.Inspire Medical Systems, Inc.Insulet CorporationIntegra LifeSciencesLivaNova PLCMasimo CorporationPenumbra, Inc.ResMed, IncTactile Systems TechnologyTandem Diabetes Care, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy